Ion Channel Genetic Biomarkers: Diagnostic Capabilities in the Assessment of Bipolar Disorder
NCT ID: NCT03572426
Last Updated: 2019-07-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
164 participants
OBSERVATIONAL
2018-06-13
2019-04-04
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Perspectives of Individuals With Bipolar Disorder and Siblings of Individuals With Bipolar Disorder; A Telephone Interview Study
NCT00300820
Psychiatric Genotype/Phenotype Project Repository
NCT00762866
Genetic Predictors of Lithium Response in Bipolar Disorder
NCT00252577
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
NCT01149551
Study of Genetic Differences in People With Depression
NCT00229463
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Bipolar
Diagnosed as having at least 1 lifetime manic episode by the MINI
genotyping all subjects
genotyping using SNaPshot genotyping method.
Depression
Diagnosed as having at least 1 Major Depressive Episode by the MINI
genotyping all subjects
genotyping using SNaPshot genotyping method.
Healthy Controls
Does not meet Criteria for any mood disorder diagnosis (MDD, BD, dysthymia)
genotyping all subjects
genotyping using SNaPshot genotyping method.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
genotyping all subjects
genotyping using SNaPshot genotyping method.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subjects must fall into one of 3 diagnostic categories, bipolar, MDD, or no mood symptoms.
Exclusion Criteria
* history of TBI
* history of untreated seizure disorder
* substance abuse in the last 8 hours
* moderate-severe substance abuse disorder diagnosed in the last 6 months
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sigma Theta Tau
UNKNOWN
University of Colorado, Denver
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kristiana Avery, PhD-c
Role: PRINCIPAL_INVESTIGATOR
University of Colorado, Denver
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Helen and Arthur E Johnson Depression Center
Aurora, Colorado, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
17-1578
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.